FAM
AVNS

Flaharty Asset Management’s Avanos Medical AVNS Stock Holding History

Flaharty Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24
Closed -$344 – 157
2025
Q1 		$344 Buy
+24
New +$375 ﹤0.01% 488
2024
Q4 		– Sell
-24
Closed -$577 – 154
2024
Q3 		$577 Buy
+24
New +$548 ﹤0.01% 433
2023
Q4 		– Sell
-24
Closed -$485 – 142
2023
Q3 		$485 Buy
+24
New +$544 ﹤0.01% 455

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Flaharty Asset Management's AVNS Position: Q2 2025 in Review

Flaharty Asset Management sold out of Avanos Medical (AVNS) in Q2 2025, closing a stake of 24 shares — an estimated $344 sold.

Flaharty Asset Management first reported a position in AVNS in Q3 2023 and held it in 3 quarters. The position peaked at $577 in Q3 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2025.

  • Flaharty Asset Management reported no remaining Avanos Medical position as of Q2 2025 after selling out during the quarter.
  • Flaharty Asset Management sold 24 Avanos Medical shares in Q2 2025, an estimated $344.
  • Flaharty Asset Management first reported a position in Avanos Medical in Q3 2023 and held it in 3 quarters.
  • Flaharty Asset Management's Avanos Medical position peaked at $577 in Q3 2024.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2025.

Based on Flaharty Asset Management's 13F filing for Q2 2025, filed 8 Aug 2025.